{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:34:26Z","timestamp":1792668866202,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sports Med"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40279-020-01318-4","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T06:02:52Z","timestamp":1594015372000},"page":"1581-1592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Overlapping Mechanisms of Exertional Heat Stroke and Malignant Hyperthermia: Evidence vs. Conjecture"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-1427","authenticated-orcid":false,"given":"Orlando","family":"Laitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin O.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"1318_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jama.286.2.168","volume":"286","author":"JR Tobin","year":"2001","unstructured":"Tobin JR. Malignant hyperthermia and apparent heat stroke. JAMA. 2001;286:168.","journal-title":"JAMA"},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cphy.c140017","volume":"5","author":"LR Leon","year":"2015","unstructured":"Leon LR, Bouchama A. Heat stroke. Compr Physiol. 2015;5:611\u201347.","journal-title":"Compr Physiol"},{"key":"1318_CR3","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/cphy.c100082","volume":"1","author":"MN Sawka","year":"2011","unstructured":"Sawka MN, Leon LR, Montain SJ, Sonna LA. Integrated physiological mechanisms of exercise performance, adaptation, and maladaptation to heat stress. Compr Physiol. 2011;1:1883\u2013928.","journal-title":"Compr Physiol"},{"key":"1318_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1249\/01.mss.0000227302.80783.0f","volume":"38","author":"WO Roberts","year":"2006","unstructured":"Roberts WO. Exertional heat stroke during a cool weather marathon: a case study. Med Sci Sports Exerc. 2006;38:1197\u2013203.","journal-title":"Med Sci Sports Exerc"},{"key":"1318_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.anclin.2019.10.010","volume":"38","author":"H Ellinas","year":"2020","unstructured":"Ellinas H, Albrecht MA. Malignant hyperthermia update. Anesthesiol Clin. 2020;38:165\u201381.","journal-title":"Anesthesiol Clin"},{"key":"1318_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/bjaceaccp\/mkh002","volume":"4","author":"J Appiah-Ankam","year":"2004","unstructured":"Appiah-Ankam J, Hunter JM. Pharmacology of neuromuscular blocking drugs. Contin Educ Anaesth Crit Care Pain. 2004;4:2\u20137.","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"1318_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/milmed\/147.1.8","volume":"147","author":"OM Jardon","year":"1982","unstructured":"Jardon OM. Physiologic stress, heat stroke, malignant hyperthermia\u2014a perspective. Mil Med. 1982;147:8\u201314.","journal-title":"Mil Med"},{"key":"1318_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1213\/ANE.0b013e3182768f99","volume":"116","author":"WA Lavezzi","year":"2013","unstructured":"Lavezzi WA, Capacchione JF, Muldoon SM, Sambuughin N, Bina S, Steele D, et al. Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old. Anesth Analg. 2013;116:420.","journal-title":"Anesth Analg"},{"key":"1318_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0960-8966(93)90114-Y","volume":"3","author":"D Figarella-Branger","year":"1993","unstructured":"Figarella-Branger D, Kozak-Ribbens G, Rodet L, Aubert M, Borsarelli J, Cozzone PJ, et al. Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscul Disord. 1993;3:553\u20136.","journal-title":"Neuromuscul Disord"},{"key":"1318_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/036354659602400109","volume":"24","author":"JW Ogletree","year":"1996","unstructured":"Ogletree JW, Antognini JF, Gronert GA. Postexercise muscle cramping associated with positive malignant hyperthermia contracture testing. Am J Sports Med. 1996;24:49\u201351.","journal-title":"Am J Sports Med"},{"key":"1318_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1213\/00000539-198005000-00011","volume":"59","author":"GA Gronert","year":"1980","unstructured":"Gronert GA, Thompson RL, Onofrio BM. Human malignant hyperthermia: awake episodes and correction by Dantrolene. Anesth Analg. 1980;59:377.","journal-title":"Anesth Analg"},{"key":"1318_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/01.pec.0000227388.91885.4b","volume":"22","author":"E Fink","year":"2006","unstructured":"Fink E, Brandom BW, Torp KD. Heatstroke in the super-sized athlete. Pediatr Emerg Care. 2006;22:510.","journal-title":"Pediatr Emerg Care"},{"key":"1318_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.4085\/1062-6050-50.12.01","volume":"50","author":"M Poussel","year":"2015","unstructured":"Poussel M, Guerci P, Kaminsky P, Heymonet M, Roux-Buisson N, Faure J, et al. Exertional heat stroke and susceptibility to malignant hyperthermia in an athlete: evidence for a link? J Athl Train. 2015;50:1212\u20134.","journal-title":"J Athl Train"},{"key":"1318_CR14","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/0140-6736(91)92304-K","volume":"338","author":"PM Hopkins","year":"1991","unstructured":"Hopkins PM, Ellis FR, Halsall PJ. Evidence for related myopathies in exertional heat stroke and malignant hyperthermia. Lancet. 1991;338:1491\u20132.","journal-title":"Lancet"},{"key":"1318_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1213\/ane.0b013e3181a9d8d9","volume":"109","author":"JF Capacchione","year":"2009","unstructured":"Capacchione JF, Muldoon SM. The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Anesth Analg. 2009;109:1065.","journal-title":"Anesth Analg"},{"key":"1318_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/01.CSMR.0000313392.79569.e7","volume":"7","author":"S Muldoon","year":"2008","unstructured":"Muldoon S, Deuster P, Voelkel M, Capacchione J, Bunger R. Exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia: is there a link? Curr Sports Med Rep. 2008;7:74.","journal-title":"Curr Sports Med Rep"},{"key":"1318_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00003677-200410000-00009","volume":"32","author":"S Muldoon","year":"2004","unstructured":"Muldoon S, Deuster P, Brandom B, Bunger R. Is there a link between malignant hyperthermia and exertional heat illness? Exerc Sport Sci Rev. 2004;32:174.","journal-title":"Exerc Sport Sci Rev"},{"key":"1318_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1152\/japplphysiol.00452.2019","volume":"127","author":"O Laitano","year":"2019","unstructured":"Laitano O, Leon LR, Roberts WO, Sawka MN. Controversies in exertional heat stroke diagnosis, prevention, and treatment. J Appl Physiol. 2019;127:1338\u201348.","journal-title":"J Appl Physiol"},{"key":"1318_CR19","doi-asserted-by":"publisher","first-page":"e0135496","DOI":"10.1371\/journal.pone.0135496","volume":"10","author":"E Sagui","year":"2015","unstructured":"Sagui E, Montigon C, Abriat A, Jouvion A, Duron-Martinaud S, Canini F, et al. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia? PLoS ONE. 2015;10:e0135496.","journal-title":"PLoS ONE"},{"key":"1318_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/cphy.c130012","volume":"4","author":"L Nybo","year":"2014","unstructured":"Nybo L, Rasmussen P, Sawka MN. Performance in the heat-physiological factors of importance for hyperthermia-induced fatigue. Compr Physiol. 2014;4:657\u201389.","journal-title":"Compr Physiol"},{"key":"1318_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1113\/jphysiol.2007.142158","volume":"586","author":"J Gonz\u00e1lez-Alonso","year":"2008","unstructured":"Gonz\u00e1lez-Alonso J, Crandall CG, Johnson JM. The cardiovascular challenge of exercising in the heat. J Physiol (Lond). 2008;586:45\u201353.","journal-title":"J Physiol (Lond)"},{"key":"1318_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4085\/1062-6050-50.9.07","volume":"50","author":"DJ Casa","year":"2015","unstructured":"Casa DJ, DeMartini JK, Bergeron MF, Csillan D, Eichner ER, Lopez RM, et al. National athletic trainers\u2019 association position statement: exertional heat illnesses. J Athl Train. 2015;50:986\u20131000.","journal-title":"J Athl Train"},{"key":"1318_CR23","first-page":"329","volume":"37","author":"HM Binkley","year":"2002","unstructured":"Binkley HM, Beckett J, Casa DJ, Kleiner DM, Plummer PE. National athletic trainers\u2019 association position statement: exertional heat illnesses. J Athl Train. 2002;37:329\u201343.","journal-title":"J Athl Train"},{"key":"1318_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/bjsm.2004.013466","volume":"39","author":"JE Smith","year":"2005","unstructured":"Smith JE. Cooling methods used in the treatment of exertional heat illness. Br J Sports Med. 2005;39:503\u20137.","journal-title":"Br J Sports Med"},{"key":"1318_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00000542-198706000-00012","volume":"66","author":"MG Larach","year":"1987","unstructured":"Larach MG, Rosenberg H, Larach DR, Broennle AM. Prediction of malignant hyperthermia susceptibility by clinical signs. Anesthesiology. 1987;66:547\u201350.","journal-title":"Anesthesiology"},{"key":"1318_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"KPE Glahn","year":"2010","unstructured":"Glahn KPE, Ellis FR, Halsall PJ, M\u00fcller CR, Snoeck MMJ, Urwyler A, et al. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth. 2010;105:417\u201320.","journal-title":"Br J Anaesth"},{"key":"1318_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00000542-198107000-00010","volume":"55","author":"IT Campbell","year":"1981","unstructured":"Campbell IT, Ellis FR, Evans RT. Metabolic rate and blood hormone and metabolite levels of individuals susceptible to malignant hyperpyrexia at rest and in response to food and mild exercise. Anesthesiology. 1981;55:46\u201352.","journal-title":"Anesthesiology"},{"key":"1318_CR28","doi-asserted-by":"publisher","first-page":"R241","DOI":"10.1152\/ajpregu.00309.2009","volume":"299","author":"LR Leon","year":"2010","unstructured":"Leon LR, Gordon CJ, Helwig BG, Rufolo DM, Blaha MD. Thermoregulatory, behavioral, and metabolic responses to heatstroke in a conscious mouse model. Am J Physiol Regul Integr Comp Physiol. 2010;299:R241\u2013248.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1318_CR29","doi-asserted-by":"publisher","first-page":"e0221329","DOI":"10.1371\/journal.pone.0221329","volume":"14","author":"MA King","year":"2019","unstructured":"King MA, Ward MD, Mayer TA, Plamper ML, Madsen CM, Cheuvront SN, et al. Influence of prior illness on exertional heat stroke presentation and outcome. PLoS ONE. 2019;14:e0221329.","journal-title":"PLoS ONE"},{"key":"1318_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1249\/MSS.0000000000000847","volume":"48","author":"WO Roberts","year":"2016","unstructured":"Roberts WO, Dorman JC, Bergeron MF. Recurrent heat stroke in a runner: race simulation testing for return to activity. Med Sci Sports Exerc. 2016;48:785\u20139.","journal-title":"Med Sci Sports Exerc"},{"key":"1318_CR31","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1177\/0363546507305013","volume":"35","author":"AS Howe","year":"2007","unstructured":"Howe AS, Boden BP. Heat-related illness in athletes. Am J Sports Med. 2007;35:1384\u201395.","journal-title":"Am J Sports Med"},{"key":"1318_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/bjsports-2016-097372.155","volume":"51","author":"N Knight","year":"2017","unstructured":"Knight N, Parkin J, Smith R, Kipps C. The incidence of exertional heat stroke during mass-participation triathlon races: optimising athlete safety. Br J Sports Med. 2017;51:344\u20135.","journal-title":"Br J Sports Med."},{"key":"1318_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/ALN.0b013e318190bb08","volume":"110","author":"EB Rosero","year":"2009","unstructured":"Rosero EB, Adesanya AO, Timaran CH, Joshi GP. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology. 2009;110:89\u201394.","journal-title":"Anesthesiology"},{"key":"1318_CR34","doi-asserted-by":"crossref","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4524368\/","DOI":"10.1186\/s13023-015-0310-1"},{"key":"1318_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/ACO.0b013e328337ffe0","volume":"23","author":"F Wappler","year":"2010","unstructured":"Wappler F. Anesthesia for patients with a history of malignant hyperthermia. Curr Opin Anaesthesiol. 2010;23:417\u201322.","journal-title":"Curr Opin Anaesthesiol"},{"key":"1318_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"N Monnier","year":"2002","unstructured":"Monnier N, Krivosic-Horber R, Payen J-F, Kozak-Ribbens G, Nivoche Y, Adnet P, et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology. 2002;97:1067\u201374.","journal-title":"Anesthesiology"},{"key":"1318_CR37","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/BF03013380","volume":"44","author":"M Bachand","year":"1997","unstructured":"Bachand M, Vachon N, Boisvert M, Mayer FM, Chartrand D. Clinical reassessment of malignant hyperthermia in Abitibi-T\u00e9miscamingue. Can J Anaesth. 1997;44:696\u2013701.","journal-title":"Can J Anaesth"},{"key":"1318_CR38","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1213\/ane.0b013e3181ac1548","volume":"109","author":"JE Brady","year":"2009","unstructured":"Brady JE, Sun LS, Rosenberg H, Li G. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001\u20132005. Anesth Analg. 2009;109:1162\u20136.","journal-title":"Anesth Analg"},{"key":"1318_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1113\/jphysiol.2013.261172","volume":"592","author":"AR Harmer","year":"2014","unstructured":"Harmer AR, Ruell PA, Hunter SK, McKenna MJ, Thom JM, Chisholm DJ, et al. Effects of type 1 diabetes, sprint training and sex on skeletal muscle sarcoplasmic reticulum Ca2+ uptake and Ca2+-ATPase activity. J Physiol (Lond). 2014;592:523\u201335.","journal-title":"J Physiol (Lond)"},{"key":"1318_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/EJA.0b013e328330404a","volume":"27","author":"HL Dhaese","year":"2010","unstructured":"Dhaese HL, Martens PR, M\u00fcller NH, Casier IM, Mulier JPJ, Heytens L. The use of emergency medical cooling system pads in the treatment of malignant hyperthermia. Eur J Anaesthesiol. 2010;27:83\u20135.","journal-title":"Eur J Anaesthesiol"},{"key":"1318_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/bja\/47.1.62","volume":"47","author":"GG Harrison","year":"1975","unstructured":"Harrison GG. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth. 1975;47:62\u20135.","journal-title":"Br J Anaesth"},{"key":"1318_CR42","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/ALN.0000000000000610","volume":"122","author":"D Fiszer","year":"2015","unstructured":"Fiszer D, Shaw M-A, Fisher NA, Carr IM, Gupta PK, Watkins EJ, et al. Next-generation sequencing of RYR1 and CACNA1S in malignant hyperthermia and exertional heat illness. Anesthesiology. 2015;122:1033\u201346.","journal-title":"Anesthes"},{"key":"1318_CR43","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/j.bja.2019.06.010","volume":"123","author":"O Mungunsukh","year":"2019","unstructured":"Mungunsukh O, Deuster P, Muldoon S, O\u2019Connor F, Sambuughin N. Estimating prevalence of malignant hyperthermia susceptibility through population genomics data. Br J Anaesth. 2019;123:e461\u2013e463463.","journal-title":"Br J Anaesth"},{"key":"1318_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","volume":"128","author":"S Riazi","year":"2018","unstructured":"Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the post-genomics era: new perspectives on an old concept. Anesthesiology. 2018;128:168\u201380.","journal-title":"Anesthesiology"},{"key":"1318_CR45","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1113\/jphysiol.2009.171967","volume":"587","author":"F Protasi","year":"2009","unstructured":"Protasi F, Paolini C, Dainese M. Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional\/environmental heat stroke. J Physiol (Lond). 2009;587:3095\u2013100.","journal-title":"J Physiol (Lond)"},{"key":"1318_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jama.1981.03320010023020","volume":"246","author":"JS Lydiatt","year":"1981","unstructured":"Lydiatt JS, Hill GE. Treatment of heat stroke with dantrolene. JAMA. 1981;246:41\u20132.","journal-title":"JAMA"},{"key":"1318_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1043-6618(05)80048-9","volume":"22","author":"OS Tayeb","year":"1990","unstructured":"Tayeb OS, Marzouki ZM. Effect of dantrolene pretreatment on heat stroke in sheep. Pharmacol Res. 1990;22:565\u201372.","journal-title":"Pharmacol Res"},{"key":"1318_CR48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/00003246-199003000-00009","volume":"18","author":"AB Channa","year":"1990","unstructured":"Channa AB, Seraj MA, Saddique AA, Kadiwal GH, Shaikh MH, Samarkandi AH. Is dantrolene effective in heat stroke patients? Crit Care Med. 1990;18:290\u20132.","journal-title":"Crit Care Med"},{"key":"1318_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00003246-199102000-00011","volume":"19","author":"A Bouchama","year":"1991","unstructured":"Bouchama A, Cafege A, Devol EB, Labdi O, El-Assil K, Seraj M. Ineffectiveness of dantrolene sodium in the treatment of heatstroke. Crit Care Med. 1991;19:176\u201380.","journal-title":"Crit Care Med"},{"key":"1318_CR50","first-page":"987","volume":"70","author":"D Moran","year":"1999","unstructured":"Moran D, Epstein Y, Wiener M, Horowitz M. Dantrolene and recovery from heat stroke. Aviat Space Environ Med. 1999;70:987\u20139.","journal-title":"Aviat Space Environ Med"},{"key":"1318_CR51","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(70)92069-6","volume":"2","author":"W Kalow","year":"1970","unstructured":"Kalow W, Britt BA, Terreau ME, Haist C. Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet. 1970;2:895\u20138.","journal-title":"Lancet"},{"key":"1318_CR52","first-page":"721","volume":"43","author":"FR Ellis","year":"1971","unstructured":"Ellis FR, Harriman DG, Keaney NP, Kyei-Mensah K, Tyrrell JH. Halothane-induced muscle contracture as a cause of hyperpyrexia. Br J Anaesth. 1971;43:721\u20132.","journal-title":"Br J Anaesth"},{"key":"1318_CR53","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/BF03006711","volume":"24","author":"W Kalow","year":"1977","unstructured":"Kalow W, Britt BA, Richter A. The caffeine test of isolated human muscle in relation to malignant hyperthermia. Can Anaesth Soc J. 1977;24:678\u201394.","journal-title":"Can Anaesth Soc J"},{"key":"1318_CR54","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.0001-5172.2004.00461.x","volume":"48","author":"D Bendahan","year":"2004","unstructured":"Bendahan D, Guis S, Monnier N, Kozak-Ribbens G, Lunardi J, Ghattas B, et al. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia. Acta Anaesthesiol Scand. 2004;48:1019\u201327.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1318_CR55","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","volume":"56","author":"The European Malignant Hyperpyrexia Group","year":"1984","unstructured":"The European Malignant Hyperpyrexia Group. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth. 1984;56:1267\u20139.","journal-title":"Br J Anaesth."},{"key":"1318_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1085\/jgp.201711864","volume":"150","author":"A Zullo","year":"2018","unstructured":"Zullo A, Textor M, Elischer P, Mall S, Alt A, Klingler W, et al. Voltage modulates halothane-triggered Ca2+ release in malignant hyperthermia-susceptible muscle. J Gen Physiol. 2018;150:111\u201325.","journal-title":"J Gen Physiol"},{"key":"1318_CR57","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1113\/jphysiol.1990.sp018120","volume":"425","author":"MG Klein","year":"1990","unstructured":"Klein MG, Simon BJ, Schneider MF. Effects of caffeine on calcium release from the sarcoplasmic reticulum in frog skeletal muscle fibres. J Physiol (Lond). 1990;425:599\u2013626.","journal-title":"J Physiol (Lond)"},{"key":"1318_CR58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bja\/aev225","volume":"115","author":"PM Hopkins","year":"2015","unstructured":"Hopkins PM, R\u00fcffert H, Snoeck MM, Girard T, Glahn KPE, Ellis FR, et al. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth. 2015;115:531\u20139.","journal-title":"Br J Anaesth"},{"key":"1318_CR59","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","volume":"41","author":"H Ording","year":"1997","unstructured":"Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, et al. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand. 1997;41:955\u201366.","journal-title":"Acta Anaesthesiol Scand."},{"key":"1318_CR60","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","volume":"88","author":"GC Allen","year":"1998","unstructured":"Allen GC, Larach MG, Kunselman AR. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS. Anesthesiology. 1998;88:579\u201388.","journal-title":"Anesthesiology"},{"key":"1318_CR61","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/00000539-200204000-00048","volume":"94","author":"CH Kindler","year":"2002","unstructured":"Kindler CH, Girard T, Gong D, Urwyler A. The differential effect of halothane and 1,2-dichlorohexafluorocyclobutane on in vitro muscle contractures of patients susceptible to malignant hyperthermia. Anesth Analg. 2002;94:1028\u201333.","journal-title":"Anesth Analg."},{"key":"1318_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/bja\/68.1.72","volume":"68","author":"L Heytens","year":"1992","unstructured":"Heytens L, Martin JJ, Van de Kelft E, Bossaert LL. In vitro contracture tests in patients with various neuromuscular diseases. Br J Anaesth. 1992;68:72\u20135.","journal-title":"Br J Anaesth"},{"key":"1318_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s005400050002","volume":"14","author":"S Oku","year":"2000","unstructured":"Oku S, Mukaida K, Nosaka S, Sai Y, Maehara Y, Yuge O. Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility. J Anesth. 2000;14:6\u201313.","journal-title":"J Anesth"},{"key":"1318_CR64","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"MG Larach","year":"1994","unstructured":"Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994;80:771\u20139.","journal-title":"Anesthesiology"},{"key":"1318_CR65","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1097\/00000542-199606000-00002","volume":"84","author":"F Wappler","year":"1996","unstructured":"Wappler F, Roewer N, Kochling A, Scholz J, Loscher W, Steinfath M, et al. Effects of the Serotonin2Receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients. Anesthesiology. 1996;84:1280\u20137.","journal-title":"Anesthes"},{"key":"1318_CR66","doi-asserted-by":"publisher","first-page":"e1854","DOI":"10.7205\/MILMED-D-16-00186","volume":"182","author":"MA Lee","year":"2017","unstructured":"Lee MA, McGlinch EB, McGlinch MC, Capacchione JF. Malignant hyperthermia susceptibility and fitness for duty. Mil Med. 2017;182:e1854\u2013e18571857.","journal-title":"Mil Med"},{"key":"1318_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007;2:21.","journal-title":"Orphanet J Rare Dis"},{"key":"1318_CR68","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12630-019-01320-z","volume":"66","author":"E Zvaritch","year":"2019","unstructured":"Zvaritch E, Gillies R, Kraeva N, Richer M, Jungbluth H, Riazi S. Fatal awake malignant hyperthermia episodes in a family with malignant hyperthermia susceptibility: a case series. Can J Anaesth. 2019;66:540\u20135.","journal-title":"Can J Anaesth"},{"key":"1318_CR69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/00913847.1987.11704818","volume":"15","author":"SL Hunter","year":"1987","unstructured":"Hunter SL, Rosenberg H, Tuttle GH, DeWalt JL, Smodic R, Martin J. Malignant hyperthermia in a college football player. Phys Sportsmed. 1987;15:77\u201381.","journal-title":"Phys Sportsmed"},{"key":"1318_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00000433-198806000-00015","volume":"9","author":"T Pamukcoglu","year":"1988","unstructured":"Pamukcoglu T. Sudden death due to malignant hyperthermia. Am J Forensic Med Pathol. 1988;9:161\u20132.","journal-title":"Am J Forensic Med Pathol"},{"key":"1318_CR71","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/BF03013392","volume":"44","author":"G Kozak-Ribbens","year":"1997","unstructured":"Kozak-Ribbens G, Bendahan D, Rodet L, Confort-Gouny S, Miri A, Talmant A, et al. Metabolic events with spontaneous malignant hyperthermia crisis in an anaesthetized pig. Can J Anaesth. 1997;44:757\u201364.","journal-title":"Can J Anaesth"},{"key":"1318_CR72","first-page":"434","volume":"58","author":"EE Gatz","year":"1973","unstructured":"Gatz EE, Wingard DW. Malignant hyperthermia. Nebr Med J. 1973;58:434\u20137.","journal-title":"Nebr Med J"},{"key":"1318_CR73","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/ALN.0b013e3182320068","volume":"115","author":"L Groom","year":"2011","unstructured":"Groom L, Muldoon SM, Tang ZZ, Brandom BW, Bayarsaikhan M, Bina S, et al. Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology. 2011;115:938\u201345.","journal-title":"Anesthes"},{"key":"1318_CR74","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/jps.2600620619","volume":"62","author":"KO Ellis","year":"1973","unstructured":"Ellis KO, Castellion AW, Honkomp LJ, Wessels FL, Carpenter JE, Halliday RP. Dantrolene, a direct acting skeletal muscle relaxant. J Pharm Sci. 1973;62:948\u201351.","journal-title":"J Pharm Sci"},{"key":"1318_CR75","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59:364\u201373.","journal-title":"Anaesthesia"}],"container-title":["Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40279-020-01318-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40279-020-01318-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40279-020-01318-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T06:17:25Z","timestamp":1650521845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40279-020-01318-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1007\/s40279-020-01318-4","relation":{},"ISSN":["0112-1642","1179-2035"],"issn-type":[{"value":"0112-1642","type":"print"},{"value":"1179-2035","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"6 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to assist in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Orlando Laitano (OL), Kevin O. Murray (KOM) and Lisa R. Leon (LRL) declare that they have no conflicts of interest relevant to the content of this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"OL and LRL outlined and wrote the first draft of the manuscript. KOM analyzed, interpreted the literature and wrote the section on IVCT. OL, KOM and LRL revised the original manuscript. All authors read and approved the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship Contributions"}}]}}